Hillsdale Investment Management Inc. Immuno Precise Antibodies Ltd. Transaction History
Hillsdale Investment Management Inc.
- $1.13 Billion
- Q1 2024
Shares
2 transactions
Others Institutions Holding IPA
# of Institutions
27Shares Held
1.67MCall Options Held
27.3KPut Options Held
23.2K-
Ingalls & Snyder LLC New York, NY1.29MShares$1.29 Million0.09% of portfolio
-
Northern Trust Corp Chicago, IL54KShares$53,9500.0% of portfolio
-
Bank Of Montreal Toronto, A653.8KShares$53,8050.0% of portfolio
-
Cibc World Market Inc. Toronto, A641.2KShares$41,2000.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny37.6KShares$37,6000.0% of portfolio
About ImmunoPrecise Antibodies Ltd.
- Ticker IPA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,836,700
- Market Cap $24.8M
- Description
- ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth ...